Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.
Clinical trial NCT04839991 · UNKNOWN
Trial details
- NCT number
- NCT04839991
- Sponsor
- Crescendo Biologics Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-08
- Primary completion
- 2024-07-25
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.